P449: NOVEL, FIRST-IN-CLASS, SOMATIC IDH2 DELETION-INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN-VITRO

• L. Ruhnke,
• D. M. Poitz,
• S. Herold,
• S. Dressler,
• C. Dill,
• M. Peitzsch,
• U. Oelschlägel,
• J. Frimmel,
• D. Kunadt,
• T. Kretschmann,
• H. Altmann,
• F. Stölzel,
• C. Röllig,
• T. Chavakis,
• G. Baretton,
• K. Schäfer-Eckart,
• M. Bornhäuser

Affiliations

L. Ruhnke

1 Department of Internal Medicine I

D. M. Poitz

2 Institute of Clinical Chemistry and Laboratory Medicine

S. Herold

3 Institute of Pathology, University Hospital Dresden, Dresden

S. Dressler

4 Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany

C. Dill

1 Department of Internal Medicine I

M. Peitzsch

2 Institute of Clinical Chemistry and Laboratory Medicine

U. Oelschlägel

1 Department of Internal Medicine I

J. Frimmel

1 Department of Internal Medicine I

D. Kunadt

1 Department of Internal Medicine I

T. Kretschmann

1 Department of Internal Medicine I

H. Altmann

1 Department of Internal Medicine I

F. Stölzel

1 Department of Internal Medicine I

C. Röllig

1 Department of Internal Medicine I

T. Chavakis

2 Institute of Clinical Chemistry and Laboratory Medicine

G. Baretton

3 Institute of Pathology, University Hospital Dresden, Dresden

K. Schäfer-Eckart

4 Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany

M. Bornhäuser

1 Department of Internal Medicine I